| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
4 companies
Celgene Corp /de/ is a 10% Owner at BRISTOL MYERS SQUIBB CO with holdings across 4 companies. Recent SEC Form 4 filings include 4 buys and 22 sells.
Estimated insider holdings value: $735.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2020 | BMY Bristol Myers Squibb Co | 10% Owner | Sell | 2,241 | $102.28 | $229,209.48 | - | |
| Jul 1, 2020 | BMY Bristol Myers Squibb Co | 10% Owner | Buy | 108,108 | $92.50 | $9,999,990.00 | +1.6% | |
| Nov 12, 2019 | AGIO Agios Pharmaceuticals, Inc. | 10% Owner | Buy | 403,225 | $31.00 | $12,499,975.00 | +29.3% | |
| Nov 21, 2018 | CRSP Crispr Therapeutics AG | 10% Owner | Sell | 1,112,446 | $18.98 | $21,118,120.42 | -1.2% | |
| Jan 23, 2018 | AGIO Agios Pharmaceuticals, Inc. | 10% Owner | Buy | 851,154 | $67.00 | $57,027,318.00 | +162.6% | |
| Oct 24, 2016 | CRSP Crispr Therapeutics AG | 10% Owner | Buy | 800,150 | $14.00 | $11,202,100.00 | +19.8% |